产品: NR1H4 抗体
货号: DF12511
描述: Rabbit polyclonal antibody to NR1H4
应用: WB IHC
文献验证: WB
反应: Human, Rat
预测: Pig, Bovine, Horse, Sheep, Rabbit, Dog
蛋白号: Q96RI1
RRID: AB_2845473

浏览相似产品>>

   规格 价格 库存
 100ul RMB¥ 2300 现货
 200ul RMB¥ 3000 现货

货期: 当天发货

联系销售

产品描述

来源:
Rabbit
应用:
WB 1:500-1:2000, IHC 1:100
*The optimal dilutions should be determined by the end user.
*Tips:

WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.

反应:
Human, Rat
克隆:
Polyclonal
特异性:
NR1H4 Antibody detects endogenous levels of total NR1H4.
RRID:
AB_2845473
引用格式: Affinity Biosciences Cat# DF12511, RRID:AB_2845473.
偶联:
Unconjugated.
纯化:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
保存:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
别名:

展开/折叠

BAR; Bile acid receptor; Farnesoid X activated receptor; Farnesoid X receptor; Farnesoid X-activated receptor; Farnesol receptor HRR 1; Farnesol receptor HRR-1; Farnesol receptor HRR1; FXR; HRR 1; HRR1; NR1H4; NR1H4_HUMAN; Nuclear receptor subfamily 1 group H member 4; Retinoid X receptor interacting protein 14; Retinoid X receptor-interacting protein 14; RIP 14; RIP14; RXR interacting protein 14; RXR-interacting protein 14;

抗原和靶标

免疫原:

A synthesized peptide derived from human NR1H4, corresponding to a region within N-terminal amino acids.

基因/基因ID:

文献引用

1). Saikosaponin D improves non-alcoholic fatty liver disease via gut microbiota-bile acid metabolism pathway. Food Science and Human Wellness, 2024 [IF=7.0]

Application: WB    Species: Mouse    Sample:

Fig. 3. SSD increased liver fatty acid oxidation and inhibited intestinal FXR signal in NAFLD mice. (A) Expression levels of liver fatty acid synthesis-related genes (n = 5). (B) Liver fatty acid oxidation-related gene expression level (n = 5). (C) Liver fatty acid oxidation-related protein expression. (D) The expression level of liver bile acid synthesis related genes. (E) Expression levels of FXR target genes (n = 5). (F) Protein expression level of intestinal FXR (n = 5). Compared with HFD group in same gene, *P < 0.05, **P < 0.01, ***P < 0.001. Compared with NCD group in same gene, #P < 0.05, ##P < 0.01, ###P < 0.001. All experiments were repeated 3 times.

2). NRF2 and FXR dual signaling pathways cooperatively regulate the effects of oleanolic acid on cholestatic liver injury. Phytomedicine, 2023 (PubMed: 36343550) [IF=6.7]

3). Ginsenosides From Panax ginseng Improves Hepatic Lipid Metabolism Disorders in HFD-Fed Rats by Regulating Gut Microbiota and Cholesterol Metabolism Signaling Pathways. Phytotherapy research : PTR, 2024 (PubMed: 39660634) [IF=6.1]

4). Construction of Humanized CYP1A2 Rats Using CRISPR/CRISPR-Associated Protein 9 to Promote Drug Metabolism and Pharmacokinetic Research. Drug Metabolism and Disposition, 2024 (PubMed: 37884392)

限制条款

产品的规格、报价、验证数据请以官网为准,官网链接:www.affbiotech.com | www.affbiotech.cn(简体中文)| www.affbiotech.jp(日本語)

产品的数据信息为Affinity所有,未经授权不得收集Affinity官网数据或资料用于商业用途,对抄袭产品数据的行为我们将保留诉诸法律的权利。

产品相关数据会因产品批次、产品检测情况随时调整,如您已订购该产品,请以订购时随货说明书为准,否则请以官网内容为准,官网内容有改动时恕不另行通知。

Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时,请您在Affinity官方渠道提交售后申请。

产品仅供科学研究使用。不用于诊断和治疗。 

产品未经授权不得转售。

Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.